Sort
10,766 grants matching “checkpoint inhibitor”
Project 2- Liquid Biopsies for Melanoma that Metastasizes to Inaccessible Sites
$315,555David A. Hafler · Yale University · P50 · FY2021 · CA
Project 3: KDM5 Histone Demethylases in Melanoma Growth and Tumor Immunity
$315,555Qin Yan · Yale University · P50 · FY2021 · CA
Project 2- Liquid Biopsies for Melanoma that Metastasizes to Inaccessible Sites
$315,543David A. Hafler · Yale University · P50 · FY2019 · CA
Project 3: KDM5 Histone Demethylases in Melanoma Growth and Tumor Immunity
$315,543Qin Yan · Yale University · P50 · FY2019 · CA
Cdk-2 Independent role of cyclin E in Cell survival
$315,543Alexandru Almasan Almasan · Cleveland Clinic Lerner Com-Cwru · R01 · FY2012 · CA
Cdk-2 Independent role of cyclin E in Cell survival
$315,543Alexandru Almasan Almasan · Cleveland Clinic Lerner Com-Cwru · R01 · FY2011 · CA
Mechanisms of Immune-mediated Tumor Cell Destruction
$315,452Thomas Sayers · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
INTEGRATION OF ONCOGENIC SIGNALS BY THE NUCLEOLAR ARF-NPM NETWORK
$315,400Jason Weber · Washington University · R01 · FY2008 · CA
INTEGRATION OF ONCOGENIC SIGNALS BY THE NUCLEOLAR ARF-NPM NETWORK
$315,400Jason Weber · Washington University · R01 · FY2010 · CA
INTEGRATION OF ONCOGENIC SIGNALS BY THE NUCLEOLAR ARF-NPM NETWORK
$315,400Jason Weber · Washington University · R01 · FY2009 · CA
Delivery of cytokines for cancer immunotherapy using nanolayer-controlled trafficking of liposomal nanoparticles
$315,363Paula T Hammond · Massachusetts Institute Of Technology · R01 · FY2023 · CA
Delivery of cytokines for cancer immunotherapy using nanolayer-controlled trafficking of liposomal nanoparticles
$315,363Paula T Hammond · Massachusetts Institute Of Technology · R01 · FY2022 · CA
Core B: Biospecimen Repository and Processing Core
$315,334Begonya Comin-Anduix · University Of California Los Angeles · P01 · FY2020 · CA
Oncolytic Adenoviruses for Glioma Therapy
$315,315Frederick F Lang · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA
A prognostic mRNA immune signature for resected stage II-III melanoma
$315,254Yvonne Margaret Saenger · Albert Einstein College Of Medicine · UH3 · FY2024 · CA
In Vivo Regulation and Inhibition of Ribonucleotide Reductase
$315,068Mingxia Huang · University Of Colorado Denver · R01 · FY2008 · CA
CDC25 PHOSPHATASES IN CELL CYCLE CONTROL AND CANCER
$315,000Helen M Piwnica-Worms · Washington University · R01 · FY2008 · GM
CDC25 PHOSPHATASES IN CELL CYCLE CONTROL AND CANCER
$315,000Helen M Piwnica-Worms · Washington University · R01 · FY2009 · GM
Targeting TRPC1: A Novel Approach to Treat Oral Cancer
$315,000Cara B Gonzales · University Of Texas Hlth Science Center · R03 · FY2025 · DE
Combining targeted radionuclide therapy with a localized in situ vaccine to overcome immune suppression in the tumor microenvironment and augment T cell responses
$314,928Paul M Sondel · University Of Wisconsin-Madison · P01 · FY2023 · CA
Mechanism(s) of Hepatocyte Transformation by the Hepatitis B Virus X Protein
$314,605Ourania M. Andrisani · Purdue University · R01 · FY2012 · DK
Project 4
$314,539Paulo Cesar Rodriguez · H. Lee Moffitt Cancer Ctr & Res Inst · P01 · FY2024 · CA
Simultaneous Radiotherapy with PD-1 and IDO1 Blockade for Overcoming Immune Suppression in Glioblastoma
$314,529Derek Alan Wainwright · Northwestern University At Chicago · P50 · FY2019 · CA
Immune Checkpoint Inhibition and humoral immune response in systemic autoimmunity
$314,441Hu Zeng · Mayo Clinic Rochester · R01 · FY2025 · AR
Function and mechanism of REDD1 signaling to TSC1/2 and mTORC1
$314,232Leif W Ellisen · Massachusetts General Hospital · R01 · FY2011 · CA